For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Tretinoin | Group 1 will receive tretinoin cream 0.05% (Vitanol A, Stiefel) that should be applied daily in areas affected by stretch marks, in both sides, for a period of 16 weeks. Tretinoin cream 0.005%: Group 1 will receive tretinoin cream 0.05%(Vitanol A, Stiefel) that should be applied daily in areas affected by stretch marks, in both sides, for a period of 16 weeks. | 0 | None | 0 | 10 | 7 | 10 | View |
| Superficial Dermabrasion | Group 2 will receive 16 sessions of dermabrasion that would be held in the research center. Superficial Dermabrasion: Group 2 will receive 16 sessions of dermabrasion that would be held in the research center | 0 | None | 0 | 12 | 7 | 12 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Erythema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Scaling | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Stinging | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |